Kallyope Receives $44,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    430 East 29th Street 8th Floor New York, NY 10016 USA
  • Company Description
    At Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Kallyope will leverage cutting edge technologies including sequencing, genetics, circuit mapping, neural imaging and bioinformatics.
  • M&A Terms
  • Venture Investor
    Lux Capital
  • Venture Investor
    Polaris Partners
  • Venture Investor
    The Column Group
  • Venture Investor
    Illumina Accelerator Program
  • Venture Investor
    Alexandria Venture Investments

Trending on Xconomy